  |
Lægemiddelstofklassifikation ATC |
M | ||
  |
Antineoplastiske og immunomodulerende midler |
ML | ||
  |
antineoplastiske stoffer |
ML01 | ||
 |
proteinkinasehæmmere |
ML01E | ||
|
epidermal vækstfaktor receptor (EGFR)-tyrosinkinasehæmmere |
ML01EB | ||
 |
gefitinib |
ML01EB01 | ||
 |
erlotinib |
ML01EB02 | ||
 |
afatinib |
ML01EB03 | ||
 |
osimertinib |
ML01EB04 | ||
 |
rociletinib |
ML01EB05 | ||
 |
olmutinib |
ML01EB06 | ||
 |
dacomitinib |
ML01EB07 | ||
 |
icotinib |
ML01EB08 | ||
 |
lazertinib |
ML01EB09 | ||
 |
mobocertinib |
ML01EB10 | ||
  |
aumolertinib |
ML01EB11 |
TEXT